These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1747 related articles for article (PubMed ID: 23506232)

  • 1. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher risk of developing mood disorders among adolescents with comorbidity of attention deficit hyperactivity disorder and disruptive behavior disorder: a nationwide prospective study.
    Chen MH; Su TP; Chen YS; Hsu JW; Huang KL; Chang WH; Chen TJ; Bai YM
    J Psychiatr Res; 2013 Aug; 47(8):1019-23. PubMed ID: 23643104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study.
    Biederman J; Wilens T; Mick E; Faraone SV; Weber W; Curtis S; Thornell A; Pfister K; Jetton JG; Soriano J
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):21-9. PubMed ID: 9000777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
    Keresztény A; Dallos G; Miklósi M; Róka A; Gádoros J; Balázs J
    Psychiatr Hung; 2012; 27(3):165-73. PubMed ID: 22781541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci.
    Jain M; Palacio LG; Castellanos FX; Palacio JD; Pineda D; Restrepo MI; Muñoz JF; Lopera F; Wallis D; Berg K; Bailey-Wilson JE; Arcos-Burgos M; Muenke M
    Biol Psychiatry; 2007 Jun; 61(12):1329-39. PubMed ID: 16950213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
    Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
    Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4-year prospective follow-up.
    Groenman AP; Oosterlaan J; Greven CU; Vuijk PJ; Rommelse N; Franke B; Hartman CA; Hoekstra PJ; Sergeant J; Faraone SV; Buitelaar J
    J Child Psychol Psychiatry; 2015 May; 56(5):521-9. PubMed ID: 25139331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance use and nicotine dependence in persistent, remittent, and late-onset ADHD: a 10-year longitudinal study from childhood to young adulthood.
    Ilbegi S; Groenman AP; Schellekens A; Hartman CA; Hoekstra PJ; Franke B; Faraone SV; Rommelse NNJ; Buitelaar JK
    J Neurodev Disord; 2018 Dec; 10(1):42. PubMed ID: 30587104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study.
    Dalsgaard S; Østergaard SD; Leckman JF; Mortensen PB; Pedersen MG
    Lancet; 2015 May; 385(9983):2190-6. PubMed ID: 25726514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder.
    Connor DF; Steeber J; McBurnett K
    J Dev Behav Pediatr; 2010 Jun; 31(5):427-40. PubMed ID: 20535081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder.
    Groenman AP; Oosterlaan J; Rommelse NN; Franke B; Greven CU; Hoekstra PJ; Hartman CA; Luman M; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Br J Psychiatry; 2013 Aug; 203(2):112-9. PubMed ID: 23846996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders.
    Biederman J; Petty CR; Wilens TE; Fraire MG; Purcell CA; Mick E; Monuteaux MC; Faraone SV
    Am J Psychiatry; 2008 Jan; 165(1):107-15. PubMed ID: 18006872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopathology and substance abuse in parents of young children with attention-deficit/hyperactivity disorder.
    Chronis AM; Lahey BB; Pelham WE; Kipp HL; Baumann BL; Lee SS
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1424-32. PubMed ID: 14627877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroanatomical correlates of attention-deficit-hyperactivity disorder accounting for comorbid oppositional defiant disorder and conduct disorder.
    Sasayama D; Hayashida A; Yamasue H; Harada Y; Kaneko T; Kasai K; Washizuka S; Amano N
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):394-402. PubMed ID: 20546170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.
    Elkins IJ; McGue M; Iacono WG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1145-52. PubMed ID: 17909126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD).
    Ohlmeier MD; Peters K; Kordon A; Seifert J; Wildt BT; Wiese B; Ziegenbein M; Emrich HM; Schneider U
    Alcohol Alcohol; 2007; 42(6):539-43. PubMed ID: 17766314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.